Evidence map›Paper›PMID 31125255›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2019

Analysis of Cre-mediated genetic deletion of

Jessica Garbern, Amy C Kristl, Vinicius Bassaneze, Ana Vujic, Henk Schoemaker, Rebecca Sereda, Liming Peng, Elisabeth M Ricci-Blair, Jill M Goldstein, Ryan G Walker and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jessica GarbernDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Amy C KristlDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Vinicius BassanezeDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Ana VujicDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Henk SchoemakerDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts.
Rebecca SeredaDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Liming PengBrigham Research Assay Core, Brigham and Women's Hospital , Boston, Massachusetts.
Elisabeth M Ricci-BlairDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Jill M GoldsteinDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Ryan G WalkerDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Shalender BhasinBrigham Research Assay Core, Brigham and Women's Hospital , Boston, Massachusetts.
Amy J WagersDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Richard T LeeDepartment of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts.
Harvard Stem Cell Institute · USHarvard University · USBrigham and Women's Hospital · US

Funding

MULTIDISCIPLINARY RESEARCH TRAINING IN CARDIOLOGYT32HL007208 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Patrick Thomas Ellinor, David E Sosnovik · 1985 to 2026
$16.1M
RESEARCH METHODS IN PEDIATRICS HEART DISEASET32HL007572 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI Sarah D DE FERRANTI, Jane W. Newburger · 1985 to 2026
$13.0M
Regulation and Function of Growth Differentiation Factor 11 During Development and AgingR01AG048917 · NIA · HARVARD UNIVERSITY · PI WAGERS, AMY JO · 2016 to 2020
$2.8M
Investigating GDF11 and MSTN as candidate circulating geronic factorsR01AG057428 · NIA · HARVARD UNIVERSITY · PI WAGERS, AMY JO · 2017 to 2020
$2.0M
A New Pathway for Reversing Cardiac AgingR01AG047131 · NIA · HARVARD UNIVERSITY · PI LEE, RICHARD T · 2015 to 2019
$1.7M
Reprogramming Non-myocytes to Cardiomyocytes in vivoR01HL119230 · NHLBI · HARVARD UNIVERSITY · PI LEE, RICHARD T · 2016 to 2019
$1.7M
Regulation and function of Growth Differentiation Factor 11 during development and agingR56AG048917 · NIA · HARVARD UNIVERSITY · PI WAGERS, AMY JO · 2015 to 2015
$338k
Regulation of Skeletal Muscle Regeneration During Aging by Growth Differentiation Factor 11F32AG050395 · NIA · HARVARD UNIVERSITY · PI GOLDSTEIN, JILL MARIE · 2015 to 2017
$121k
NHLBI NIH HHS R01 HL119230NHLBI NIH HHS T32 HL007208NHLBI NIH HHS T32 HL007572NIA NIH HHS F32 AG050395NIA NIH HHS R01 AG047131NIA NIH HHS R01 AG048917NIA NIH HHS R01 AG057428NIA NIH HHS R56 AG048917
6 · The paper itself

Abstract

Administration of active growth differentiation factor 11 (GDF11) to aged mice can reduce cardiac hypertrophy, and low serum levels of GDF11 measured together with the related protein, myostatin (also known as GDF8), predict future morbidity and mortality in coronary heart patients. Using mice with a loxP-flanked ("floxed") allele of

Indexed as

Gene DeletionAge FactorsAnimalsBone Morphogenetic ProteinsCardiomyopathy, DilatedDisease ProgressionFemaleGene Knockdown TechniquesGenetic Predisposition to DiseaseGrowth Differentiation FactorsIntegrasesMaleMice, Inbred C57BLMice, KnockoutMyocytes, CardiacMyosin Heavy ChainsBone Morphogenetic ProteinsCre recombinaseGdf11 protein, mouseGrowth Differentiation FactorsIntegrasesMyh6 protein, mouseMyosin Heavy Chainscardiomyocytescardiomyopathygrowth differentiation factor 11Myh6-cremyostatin

Identifiers

PMID31125255
PMCPMC6692736
OpenAlexW2946336453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.